Participation in phase 1 trials for patients with cancer

The Lancet, Sept. 2022

Antoine Italiano

https://www.sciencedirect.com/science/article/abs/pii/S0140673622015331

DOI: 10.1016/S0140-6736(22)01533-1

No abstract available